991 resultados para Embaràs múltiple
Resumo:
Aquest qüestionari pretén valorar la teva experiència en la participació del projecte que desenvolupes en la universitat. El qüestionari és anònim i no trigaràs més de 15 minuts en respondre'l.
Resumo:
Aquest qüestionari pretén valorar l’experiència dels estudiants dins del projecte d’Aprenentatge i Servei que promous. El qüestionari és confidencial i no trigaràs més de 15 minuts en respondre'l.
Resumo:
Aquest qüestionari pretén valorar l’experiència dels estudiants dins del projecte d’Aprenentatge i Servei que promous. El qüestionari és confidencial i no trigaràs més de 15 minuts en respondre'l.
Resumo:
Aquest qüestionari pretén valorar l’experiència dels estudiants dins del projecte d’Aprenentatge i Servei que promous. El qüestionari és confidencial i no trigaràs més de 15 minuts en respondre'l.
Resumo:
Aquest qüestionari pretén valorar l’experiència dels estudiants dins del projecte d’Aprenentatge i Servei que promous. El qüestionari és confidencial i no trigaràs més de 15 minuts en respondre'l.
Resumo:
Aquest qüestionari pretén valorar l’experiència dels estudiants dins del projecte d’Aprenentatge i Servei que promous. El qüestionari és confidencial i no trigaràs més de 15 minuts en respondre'l.
Resumo:
About 85% of multiple sclerosis (MS) cases start as clinically isolated syndrome (CIS).When patients present with a CIS, clinicians face with many questions, most of themrelated with prognosis and treatment. Thereby, patients with CIS have been focus ofresearch. Several studies have demonstrated a relationship between positive IgM lipidspecific oligoclonal band pattern in CSF and higher lesion load on MRI brain scan, higher number of relapses and greater disability, even at the first stages of the disease. On the other hand, no studies have used this previous evidence to treat with more aggressive disease modifying therapy in initial stages of disease course to prevent the earlier axonal damage. The aim of this study is to assess the most effective approved treatment for MS and current therapy for CIS patients presenting high risk to develop CDMS and with biomarkers of poor prognosis. Among this group of patients any disease activity will eventually lead to disability. Therefore, the earlier the treatment is initiated, the more effective to prevent disability will be. It is considered that “time lost is brain lost” and since once damage is established, there is no therapy to be regained later on. In this phase III clinical trial, 172 patients will be randomized 1:1 to receive Interferon β-1b or natalizumab over 96 weeks. Time to develop clinical definitive multiple sclerosis (CDMS) will be included as primary endpoint. Other secondary endpoints will include clinical data, magnetic resonance imaging (MRI) measurements and quality of life tests
Resumo:
There are not enough previous publications which are focused on mothers withwell-controlled gestational diabetes mellitus (GDM) as a risk factor that determines the occurrence of neonatal hypoglycemia. In addition, approaches to blood glucose monitoring have been inconsistent and poorly defined. Our objective is to determine if being a newborn from a mother with well-controlled gestational diabetes (regardless insulin treatment) have a higher risk to develop hypoglycemia than a healthy newborn, using a defined and strict protocol. The project will take place in a regional hospital of Girona. We will recruit from 2014 to 2015 a cohort of 623 infants born in this center without any malformation or any perinatal pathology or complication, selected with a consecutive sampling. We will record sex, ethnicity and gestational age information. We will measure blood glucose levels and anthropometric measurements in newborns always taking into account the presence of well-controlled maternal gestational diabetes or not. Patients will be followed up during 24 hours to determine the incidence of hypoglycemia. We will analyze the contribution between exposure factors that we have studied and the incidence of the outcome using a multivariate analysis
Resumo:
Pregunta: ?Es segura la administración de los fármacos que inhiben el factor de necrosis tumoral a (TNF-a) durante el embarazo? Respuesta: En los últimos años se han desarrollado medicamentos que inhiben el TNF-a, porque esta citocina tiene un efecto inflamatorio que condiciona el proceso patológico de diversas enfermedades autoinmunitarias sistémicas, como artritis reumatoide, psoriasis, enfermedades inflamatorias intestinales y otras. Actualmente existen en el mercado farmacéutico 5 fármacos que...
Resumo:
This questionnaire aims to evaluate your experience of taking part in the project you are carrying out at the university. The questionnaire is anonymous and will not take more than 10 minutes of your time to complete. We would appreciate your honest opinion, in order that the data we gather here can be as useful as possible for improving the project.
Resumo:
This questionnaire aims to evaluate your experience of taking part in the project you are carrying out at the university. The questionnaire is anonymous and will not take more than 10 minutes of your time to complete. We would appreciate your honest opinion, in order that the data we gather here can be as useful as possible for improving the project.
Resumo:
This questionnaire aims to evaluate your experience of taking part in the project you are carrying out at the university. The questionnaire is anonymous and will not take more than 10 minutes of your time to complete. We would appreciate your honest opinion, in order that the data we gather here can be as useful as possible for improving the project.
Resumo:
This questionnaire aims to evaluate your experience of taking part in the project you are carrying out at the university. The questionnaire is anonymous and will not take more than 10 minutes of your time to complete. We would appreciate your honest opinion, in order that the data we gather here can be as useful as possible for improving the project.
Resumo:
En el curso académico 2007/2008 introdujimos en la asignatura de Anatomía Humana de primer curso un sistema de evaluación continua a través del Campus Moodle. El curso 2010/2011 introdujimos un cambio en el sistema de evaluación continua, que se ha mantenido en el pasado curso 2011/212. Como en los cursos precedentes, se pasaron tres cuestionarios con preguntas de elección múltiple a los estudiantes, uno para cada bloque de la asignatura, pero en este curso con la herramienta Cuestionario de Moodle. Para saber la opinión de los estudiantes respecto a este nuevo modelo evaluativo les pasamos un cuestionario Google.